These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

649 related articles for article (PubMed ID: 25760330)

  • 21. The role of miR-409-3p in regulation of HPV16/18-E6 mRNA in human cervical high-grade squamous intraepithelial lesions.
    Sommerova L; Anton M; Bouchalova P; Jasickova H; Rak V; Jandakova E; Selingerova I; Bartosik M; Vojtesek B; Hrstka R
    Antiviral Res; 2019 Mar; 163():185-192. PubMed ID: 30711417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. E6/E7 and E6
    Artaza-Irigaray C; Molina-Pineda A; Aguilar-Lemarroy A; Ortiz-Lazareno P; Limón-Toledo LP; Pereira-Suárez AL; Rojo-Contreras W; Jave-Suárez LF
    Front Immunol; 2019; 10():1676. PubMed ID: 31396215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
    Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
    Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CRISPR/Cas9-based inactivation of human papillomavirus oncogenes E6 or E7 induces senescence in cervical cancer cells.
    Inturi R; Jemth P
    Virology; 2021 Oct; 562():92-102. PubMed ID: 34280810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-135a leads to cervical cancer cell transformation through regulation of β-catenin via a SIAH1-dependent ubiquitin proteosomal pathway.
    Leung CO; Deng W; Ye TM; Ngan HY; Tsao SW; Cheung AN; Pang RT; Yeung WS
    Carcinogenesis; 2014 Sep; 35(9):1931-40. PubMed ID: 24503442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene silencing of HPV16 E6/E7 induced by promoter-targeting siRNA in SiHa cells.
    Hong D; Lu W; Ye F; Hu Y; Xie X
    Br J Cancer; 2009 Nov; 101(10):1798-804. PubMed ID: 19826423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inactivation of the human papillomavirus E6 or E7 gene in cervical carcinoma cells by using a bacterial CRISPR/Cas RNA-guided endonuclease.
    Kennedy EM; Kornepati AV; Goldstein M; Bogerd HP; Poling BC; Whisnant AW; Kastan MB; Cullen BR
    J Virol; 2014 Oct; 88(20):11965-72. PubMed ID: 25100830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced miR-34a expression in normal cervical tissues and cervical lesions with high-risk human papillomavirus infection.
    Li B; Hu Y; Ye F; Li Y; Lv W; Xie X
    Int J Gynecol Cancer; 2010 May; 20(4):597-604. PubMed ID: 20442590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Up-regulation of miR-20a by HPV16 E6 exerts growth-promoting effects by targeting PDCD6 in cervical carcinoma cells.
    Liu X
    Biomed Pharmacother; 2018 Jun; 102():996-1002. PubMed ID: 29710555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracellular and exosomal microRNAome profiling of human vascular smooth muscle cells during replicative senescence.
    Nguyen DDN; Zain SM; Kamarulzaman MH; Low TY; Chilian WM; Pan Y; Ting KN; Hamid A; Abdul Kadir A; Pung YF
    Am J Physiol Heart Circ Physiol; 2021 Oct; 321(4):H770-H783. PubMed ID: 34506226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HPV-16 E6/E7 promotes cell migration and invasion in cervical cancer via regulating cadherin switch in vitro and in vivo.
    Hu D; Zhou J; Wang F; Shi H; Li Y; Li B
    Arch Gynecol Obstet; 2015 Dec; 292(6):1345-54. PubMed ID: 26093522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells.
    Martinez I; Gardiner AS; Board KF; Monzon FA; Edwards RP; Khan SA
    Oncogene; 2008 Apr; 27(18):2575-82. PubMed ID: 17998940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of MicroRNAs That Stabilize p53 in Human Papillomavirus-Positive Cancer Cells.
    Martínez-Noël G; Szajner P; Kramer RE; Boyland KA; Sheikh A; Smith JA; Howley PM
    J Virol; 2022 Feb; 96(4):e0186521. PubMed ID: 34878887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.
    Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D
    Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of HPV-16 infection on hypopharyngeal squamous cell carcinoma and FaDu cells.
    Lu W; Feng L; Li P; Wang Y; Du Y; Chen X; Wu S; Zhao G; Lou W
    Oncol Rep; 2016 Jan; 35(1):99-106. PubMed ID: 26497405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of cervical cancer cell growth by human papillomavirus virus-like particles packaged with human papillomavirus oncoprotein short hairpin RNAs.
    Bousarghin L; Touze A; Gaud G; Iochmann S; Alvarez E; Reverdiau P; Gaitan J; Jourdan ML; Sizaret PY; Coursaget PL
    Mol Cancer Ther; 2009 Feb; 8(2):357-65. PubMed ID: 19174559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The combinational effect of E6/E7 siRNA and anti-miR-182 on apoptosis induction in HPV16-positive cervical cells.
    Javadi H; Lotfi AS; Hosseinkhani S; Mehrani H; Amani J; Soheili ZS; Hojati Z; Kamali M
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):727-736. PubMed ID: 29873516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two less common human microRNAs miR-875 and miR-3144 target a conserved site of E6 oncogene in most high-risk human papillomavirus subtypes.
    Lin L; Cai Q; Zhang X; Zhang H; Zhong Y; Xu C; Li Y
    Protein Cell; 2015 Aug; 6(8):575-588. PubMed ID: 25913515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene Targeting of HPV18 E6 and E7 Synchronously by Nonviral Transfection of CRISPR/Cas9 System in Cervical Cancer.
    Ling K; Yang L; Yang N; Chen M; Wang Y; Liang S; Li Y; Jiang L; Yan P; Liang Z
    Hum Gene Ther; 2020 Mar; 31(5-6):297-308. PubMed ID: 31989837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcription factor homeobox D9 is involved in the malignant phenotype of cervical cancer through direct binding to the human papillomavirus oncogene promoter.
    Hirao N; Iwata T; Tanaka K; Nishio H; Nakamura M; Morisada T; Morii K; Maruyama N; Katoh Y; Yaguchi T; Ohta S; Kukimoto I; Aoki D; Kawakami Y
    Gynecol Oncol; 2019 Nov; 155(2):340-348. PubMed ID: 31477279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.